title: A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. 2004.
authors.forename: Pirow J
authors.initials: PJ
authors.lastname: Bekker
authors.forename: Donna L
authors.initials: DL
authors.lastname: Holloway
authors.forename: Amy S
authors.initials: AS
authors.lastname: Rasmussen
authors.forename: Robyn
authors.initials: R
authors.lastname: Murphy
authors.forename: Steven W
authors.initials: SW
authors.lastname: Martin
authors.forename: Philip T
authors.initials: PT
authors.lastname: Leese
authors.forename: Gregory B
authors.initials: GB
authors.lastname: Holmes
authors.forename: Colin R
authors.initials: CR
authors.lastname: Dunstan
authors.forename: Alex M
authors.initials: AM
authors.lastname: DePaoli
mesh_terms: D000911:Antibodies, Monoclonal / Q000266:history / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002352:Carrier Proteins / Q000276:immunology; D000069448:Denosumab; D005260:Female; D049674:History, 21st Century; D006801:Humans; D008562:Membrane Glycoproteins / Q000276:immunology; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000266:history; D053245:RANK Ligand; D016032:Randomized Controlled Trials as Topic; D053246:Receptor Activator of Nuclear Factor-kappa B
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D002352:Carrier Proteins; D008562:Membrane Glycoproteins; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; C505686:TNFRSF11A protein, human; C505688:TNFSF11 protein, human; D000069448:Denosumab